Bio-Path Holdings, Inc. (BPTH) DCF Valuation

Bio-Path Holdings, Inc. (BPTH) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Bio-Path Holdings, Inc. (BPTH) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Bio-Path Holdings, Inc. (BPTH) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Obtenga información sobre su análisis de valoración de Bio-Path Holdings, Inc. (BPTH) utilizando nuestra sofisticada calculadora DCF! Antes de datos reales (BPTH), esta plantilla de Excel le permite ajustar los pronósticos y supuestos para determinar con precisión el valor intrínseco de Bio-Path Holdings, Inc.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -8.4 -10.7 -10.3 -13.7 -15.8 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .2 .2 .2 .2 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -8.6 -10.9 -10.4 -13.9 -15.8 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 20.4 13.8 23.8 10.4 1.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .5 .1 .1 .7 .5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 -.1 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -8.5 -10.9 -10.4 -13.8 -15.8 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.8 -11.1 -10.3 -13.1 -16.0 -.5 .0 .0 .0 .0
WACC, % 5.31 5.32 5.32 5.32 5.32 5.32 5.32 5.32 5.32 5.32
PV UFCF
SUM PV UFCF -.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -1
Equity Value 1
Diluted Shares Outstanding, MM 0
Equity Value Per Share 1.06

What You Will Get

  • Comprehensive BPTH Financials: Access to both historical and projected data for precise valuation.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures to fit your analysis.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Testing: Explore various scenarios to assess Bio-Path Holdings’ future performance.
  • User-Friendly Interface: Designed for industry professionals while being easy to navigate for newcomers.

Key Features

  • 🔍 Real-Life BPTH Financials: Pre-filled historical and projected data for Bio-Path Holdings, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Bio-Path's intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Bio-Path's valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Bio-Path Holdings data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Bio-Path Holdings’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Bio-Path Holdings, Inc. (BPTH)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio evaluations tailored for BPTH.
  • Flexible Inputs: Modify the yellow-highlighted fields to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes Bio-Path's intrinsic value and Net Present Value.
  • Preloaded Information: Access to historical and projected data for precise analysis.
  • Expert-Level Tool: Perfect for financial analysts, investors, and business advisors focusing on BPTH.

Who Should Use This Product?

  • Investors: Evaluate Bio-Path Holdings, Inc. (BPTH) for informed stock trading decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess future projections for BPTH.
  • Startup Founders: Understand the valuation strategies of established biotech firms like Bio-Path Holdings, Inc. (BPTH).
  • Consultants: Create detailed valuation reports to guide clients in the biotech sector.
  • Students and Educators: Utilize real-time data from Bio-Path Holdings, Inc. (BPTH) to teach and learn valuation practices.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Bio-Path Holdings, Inc. (BPTH) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Bio-Path Holdings, Inc. (BPTH).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.